These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 714726

  • 21. A randomized prospective controlled study of the metabolism and hepatotoxicity of halothane in humans.
    Cousins MJ, Gourlay GK, Knights KM, Hall PD, Lunam CA, O'Brien P.
    Anesth Analg; 1987 Apr; 66(4):299-308. PubMed ID: 3565792
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Pharmacokinetics of phenazone as an indicator of the metabolic capacity of the liver in patients with hyperthyroidism].
    Orzechowska-Juzwenko K, Bolanowski M, Gruszka S, Szymczak J.
    Pol Tyg Lek; 1987 Apr; 38(20-21):643-5. PubMed ID: 6647129
    [No Abstract] [Full Text] [Related]

  • 24. [Evaluation of the capacity of the liver for phenazone biotransformation in patients with uremia on peritoneal dialysis].
    Grzegorzewska A, Lowicki Z, Chmara E, Mrozikiewicz A, Baczyk K.
    Pol Tyg Lek; 1987 Apr; 45(16-18):339-41. PubMed ID: 2235722
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Noninvasive kinetic approach to the estimation of total hepatic blood flow and shunting in chronic liver disease--a hypothesis.
    McLean A, du Souich P, Gibaldi M.
    Clin Pharmacol Ther; 1979 Feb; 25(2):161-6. PubMed ID: 759068
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Alteration of hepatic drug metabolism in female patients with congestive cardiac failure.
    Rissam HS, Nair CR, Anand IS, Madappa C, Wahi PL.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):602-4. PubMed ID: 6668098
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Effect of beta-adrenolytic drugs on hepatic clearance of antipyrine].
    Adamska-Dyniewska H, Pruszczyński J, Wichan P.
    Pol Arch Med Wewn; 1984 Feb; 71(2):71-7. PubMed ID: 6146126
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Evaluation of the metabolizing function of the liver in thyrotoxicosis using the antipyrine test].
    Salakhova NS, Nazhmutdinova DK.
    Probl Endokrinol (Mosk); 1987 Feb; 33(1):9-11. PubMed ID: 3823028
    [Abstract] [Full Text] [Related]

  • 39. [Antipyrine test in evaluation of the functional state of the liver in the postoperative period].
    Nadzhimutdinov KN, Krakovskiĭ ME, Ashirmetov AKh, Komarin AS, Kaiumov TKh.
    Khirurgiia (Mosk); 1986 Feb; (2):21-3. PubMed ID: 3959450
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.